GlassScriptPhysician profile
Ronald D Davis
NPI 1255351367
$6,401.86
in general payments reported to CMS, 2019-2025
37 companies · $758 in 2025
The $758 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,222 · 2020: $583 · 2021: $1,090 · 2022: $1,132 · 2023: $647 · 2024: $970 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908 · Education: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.78 |
| Education | $466.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,543.25 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $823.19 | 2019-2025 | Erleada |
| Teleflex LLC | $614.09 | 2021-2025 | Urolift, Barrigel |
| Myriad Genetic Laboratories, INC. | $397.28 | 2021-2024 | Prolaris |
| Pfizer INC. | $375.07 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $304.70 | 2020-2022 | |
| Allergan, INC. | $302.68 | 2019-2021 | |
| Procept Biorobotics Corporation | $277.05 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $267.66 | 2019-2023 | Spaceoar Vue System - 10ml |
| Endo Pharmaceuticals INC. | $247.10 | 2019-2024 | Xiaflex, Aveed |
| Dendreon Pharmaceuticals LLC | $186.78 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $145.08 | 2023-2025 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $137.72 | 2021-2025 | Pylarify |
| Dornier Medtech America, INC | $114.10 | 2022 | |
| Urogen Pharma, INC. | $66.58 | 2021-2025 | Jelmyto |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $58.06 | 2021 | |
| Cook Medical LLC | $55.33 | 2019-2021 | |
| Urovant Sciences INC | $50.49 | 2022 | |
| Coloplast Corp | $43.34 | 2021-2024 | |
| Abbvie INC. | $36.74 | 2023-2024 | Botox |
| Steris Corporation | $35.63 | 2024 | |
| Endo USA, INC. | $35.40 | 2025 | Aveed, Xiaflex |
| Amgen INC. | $32.15 | 2019 | |
| Calyxo, INC. | $28.32 | 2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $23.87 | 2021 | |
| Blue Earth Diagnostics | $22.92 | 2020 | |
| Telix Pharmaceuticals | $22.40 | 2025 | Illuccix |
| Ethicon US, LLC | $22.37 | 2020 | |
| Olympus America INC. | $21.81 | 2024 | Itind System |
| Tolmar Pharmaceuticals, INC. | $17.37 | 2019 | |
| Innovation Technologies INC | $16.18 | 2024 | Irrisept |
| Hollister Incorporated | $15.85 | 2022 | |
| 180 Medical, INC. | $14.88 | 2019 | |
| Photocure INC | $14.40 | 2024 | Cysview |
| Axonics, INC. | $13.42 | 2022 | |
| Tersera Therapeutics LLC | $11.77 | 2019 | |
| Ambu INC. | $6.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.